A Study on Bioequivalence of Cabergoline Tablets in Human Body
Clinical trial NCT07008417 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07008417
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2026-02-03
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.